Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Epidemiology and Infection
|
February 1, 2003
Is household antibiotic use a risk factor for antibiotic-resistant pneumococcal infection?
T S Kwan-Gett, R L Davis, D K Shay, et al.
The Pediatric Infectious Disease Journal
|
December 23, 1999
Postmarketing evaluation of the safety and effectiveness of varicella vaccine
S Black, H Shinefield, P Ray, et al.
JAMA
|
August 20, 1997
Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team
P Ray, S Black, H Shinefield, et al.
Pediatrics
|
November 14, 1997
MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team
R L Davis, E Marcuse, S Black, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 14, 2004
Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemia
L Spector, F Groves, F DeStefano, et al.
The New England Journal of Medicine
|
January 29, 2000
Influenza and the rates of hospitalization for respiratory disease among infants and young children
H S Izurieta, W W Thompson, P Kramarz, et al.
Journal of Clinical Epidemiology
|
June 23, 1998
Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD)
M T Niu, P Rhodes, M Salive, et al.
The Pediatric Infectious Disease Journal
|
May 3, 2001
Population-based study of rotavirus vaccination and intussusception
P Kramarz, E K France, F Destefano, et al.
Archives of Pediatrics & Adolescent Medicine
|
March 20, 2001
Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project
R L Davis, P Kramarz, K Bohlke, et al.
The Pediatric Infectious Disease Journal
|
April 5, 2000
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group
S Black, H Shinefield, B Fireman, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Epidemiology and Infection
|
February 1, 2003
Is household antibiotic use a risk factor for antibiotic-resistant pneumococcal infection?
T S Kwan-Gett, R L Davis, D K Shay, et al.
The Pediatric Infectious Disease Journal
|
December 23, 1999
Postmarketing evaluation of the safety and effectiveness of varicella vaccine
S Black, H Shinefield, P Ray, et al.
JAMA
|
August 20, 1997
Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team
P Ray, S Black, H Shinefield, et al.
Pediatrics
|
November 14, 1997
MMR2 immunization at 4 to 5 years and 10 to 12 years of age: a comparison of adverse clinical events after immunization in the Vaccine Safety Datalink project. The Vaccine Safety Datalink Team
R L Davis, E Marcuse, S Black, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 14, 2004
Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemia
L Spector, F Groves, F DeStefano, et al.
The New England Journal of Medicine
|
January 29, 2000
Influenza and the rates of hospitalization for respiratory disease among infants and young children
H S Izurieta, W W Thompson, P Kramarz, et al.
Journal of Clinical Epidemiology
|
June 23, 1998
Comparative safety of two recombinant hepatitis B vaccines in children: data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD)
M T Niu, P Rhodes, M Salive, et al.
The Pediatric Infectious Disease Journal
|
May 3, 2001
Population-based study of rotavirus vaccination and intussusception
P Kramarz, E K France, F Destefano, et al.
Archives of Pediatrics & Adolescent Medicine
|
March 20, 2001
Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project
R L Davis, P Kramarz, K Bohlke, et al.
The Pediatric Infectious Disease Journal
|
April 5, 2000
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group
S Black, H Shinefield, B Fireman, et al.
Page
of 3